Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2001

Open Access 01-10-2001 | Research article

Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis

Authors: Charles Kaplan, Juan C Valdez, Raman Chandrasekaran, Hermann Eibel, Katalin Mikecz, Tibor T Glant, Alison Finnegan

Published in: Arthritis Research & Therapy | Issue 1/2001

Login to get access

Abstract

BALB/c mice immunized with human cartilage proteoglycan (PG) develop arthritis accompanied by the production of autoantibodies to mouse cartilage PG. To determine whether the autoantibody isotype contributes to the onset and severity of arthritis, PG-specific serum IgG1 (Th2, IL-4-cytokine-supporting) and IgG2a (Th1, IFN-γ-controlling) concentrations were monitored during immunization with PG in IL-4-deficient and IFN-γ-deficient mice. Paradoxically, despite elevated IFN-γ, the PG-specific IgG1 isotype was significantly higher than the PG-specific IgG2a response, and the PG-specific IgG1 isotype was independent of IL-4. In contrast, the serum concentration of PG-specific IgG2a isotype was six times higher in IL-4-deficient mice than in wild-type controls. Moreover, the high concentration of PG-specific IgG2a isotype in IL-4-deficient mice corresponded to an increased severity of arthritis. The concentration of PG-specific IgG2a isotype was lower in IFN-γ-deficient mice than in wild-type mice, and the incidence and severity of arthritis also were significantly lower. Concentrations of PG-specific IgG2a isotype autoantibody correlated with the onset and severity of arthritis, suggesting a pathological role of this isotype, probably locally in the joint.
Literature
1.
go back to reference Glant TT, Mikecz K, Arzoumanian A, Poole AR: Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 1987, 30: 201-212.PubMedCrossRef Glant TT, Mikecz K, Arzoumanian A, Poole AR: Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 1987, 30: 201-212.PubMedCrossRef
2.
go back to reference Mikecz K, Glant TT, Poole AR: Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 1987, 30: 306-318.PubMedCrossRef Mikecz K, Glant TT, Poole AR: Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 1987, 30: 306-318.PubMedCrossRef
3.
go back to reference Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K: Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum. 1998, 41: 1007-1018. 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6.PubMedCrossRef Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K: Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum. 1998, 41: 1007-1018. 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6.PubMedCrossRef
4.
go back to reference Finnegan A, Mikecz K, Tao P, Glant TT: Proteoglycan (Aggre-can)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol. 1999, 163: 5383-5390.PubMed Finnegan A, Mikecz K, Tao P, Glant TT: Proteoglycan (Aggre-can)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol. 1999, 163: 5383-5390.PubMed
5.
go back to reference Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K: Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol. 1998, 160: 3812-3819.PubMed Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K: Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol. 1998, 160: 3812-3819.PubMed
6.
go back to reference Mikecz K, Glant TT, Buzas E, Poole AR: Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 1990, 33: 866-876.PubMedCrossRef Mikecz K, Glant TT, Buzas E, Poole AR: Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 1990, 33: 866-876.PubMedCrossRef
7.
go back to reference Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR: Cartilage pro-teoglycan-induced arthritis in BALB/c mice. Antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis. Arthritis Rheum. 1990, 33: 1394-1405.PubMedCrossRef Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR: Cartilage pro-teoglycan-induced arthritis in BALB/c mice. Antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis. Arthritis Rheum. 1990, 33: 1394-1405.PubMedCrossRef
8.
go back to reference Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990, 8: 303-333. 10.1146/annurev.iy.08.040190.001511.PubMedCrossRef Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990, 8: 303-333. 10.1146/annurev.iy.08.040190.001511.PubMedCrossRef
9.
go back to reference Paul WE: Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991, 77: 1859-1870.PubMed Paul WE: Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991, 77: 1859-1870.PubMed
10.
go back to reference Snapper CM, Finkelman FD, Paul WE: Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev. 1988, 102: 51-75.PubMedCrossRef Snapper CM, Finkelman FD, Paul WE: Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev. 1988, 102: 51-75.PubMedCrossRef
11.
go back to reference Ochel M, Vohr HW, Pfeiffer C, Gleichmann E: IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol. 1991, 146: 3006-3011.PubMed Ochel M, Vohr HW, Pfeiffer C, Gleichmann E: IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol. 1991, 146: 3006-3011.PubMed
12.
go back to reference Finkelman FD, Urban JF, Beckmann MP, Schooley KA, Holmes JM, Katona IM: Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int Immunol. 1991, 3: 599-607.PubMedCrossRef Finkelman FD, Urban JF, Beckmann MP, Schooley KA, Holmes JM, Katona IM: Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int Immunol. 1991, 3: 599-607.PubMedCrossRef
13.
go back to reference Estes DM, Teale JM: In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB/c mice. Infect Immun. 1991, 59: 836-842.PubMedPubMedCentral Estes DM, Teale JM: In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB/c mice. Infect Immun. 1991, 59: 836-842.PubMedPubMedCentral
14.
go back to reference Finkelman FD, Katona IM, Mosmann TR, Coffman RL: IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol. 1988, 140: 1022-1027.PubMed Finkelman FD, Katona IM, Mosmann TR, Coffman RL: IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol. 1988, 140: 1022-1027.PubMed
15.
go back to reference Snapper CM, Peschel C, Paul WE: IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol. 1988, 140: 2121-2127.PubMed Snapper CM, Peschel C, Paul WE: IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol. 1988, 140: 2121-2127.PubMed
16.
go back to reference Snapper CM, Paul WE: Interferon-gamma and B cell stimula-tory factor-1 reciprocally regulate Ig isotype production. Science. 1987, 236: 944-947.PubMedCrossRef Snapper CM, Paul WE: Interferon-gamma and B cell stimula-tory factor-1 reciprocally regulate Ig isotype production. Science. 1987, 236: 944-947.PubMedCrossRef
17.
go back to reference Berton MT, Uhr JW, Vitetta ES: Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma. Proc Natl Acad Sci U S A. 1989, 86: 2829-2833.PubMedPubMedCentralCrossRef Berton MT, Uhr JW, Vitetta ES: Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma. Proc Natl Acad Sci U S A. 1989, 86: 2829-2833.PubMedPubMedCentralCrossRef
18.
go back to reference Hollo K, Glant TT, Garzo M, Finnegan A, Mikecz K, Buzas E: Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol. 2000, 120: 167-173. 10.1046/j.1365-2249.2000.01174.x.PubMedPubMedCentralCrossRef Hollo K, Glant TT, Garzo M, Finnegan A, Mikecz K, Buzas E: Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol. 2000, 120: 167-173. 10.1046/j.1365-2249.2000.01174.x.PubMedPubMedCentralCrossRef
19.
go back to reference Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM, Cheever AW, Paul WE, Sher A: Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol. 1999, 163: 337-342.PubMed Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM, Cheever AW, Paul WE, Sher A: Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol. 1999, 163: 337-342.PubMed
20.
go back to reference Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR: IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol. 1997, 158: 5997-6005.PubMed Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR: IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol. 1997, 158: 5997-6005.PubMed
21.
go back to reference Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Bra-ciale TJ: Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med. 1993, 178: 1725-1732.PubMedCrossRef Graham MB, Dalton DK, Giltinan D, Braciale VL, Stewart TA, Bra-ciale TJ: Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med. 1993, 178: 1725-1732.PubMedCrossRef
22.
go back to reference Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, Pollard KM: The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol. 1998, 161: 234-240.PubMed Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, Pollard KM: The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol. 1998, 161: 234-240.PubMed
23.
go back to reference Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J: In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol. 1996, 26: 2062-2066.PubMedCrossRef Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J: In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol. 1996, 26: 2062-2066.PubMedCrossRef
24.
go back to reference Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S: Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med. 2000, 191: 1293-1302. 10.1084/jem.191.8.1293.PubMedPubMedCentralCrossRef Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S: Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med. 2000, 191: 1293-1302. 10.1084/jem.191.8.1293.PubMedPubMedCentralCrossRef
25.
go back to reference Gautam S, Tebo JM, Hamilton TA: IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages. J Immunol. 1992, 148: 1725-1730.PubMed Gautam S, Tebo JM, Hamilton TA: IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages. J Immunol. 1992, 148: 1725-1730.PubMed
26.
go back to reference Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Liv-ingston DM, Kung AL, Cereb N, Yao T-P, Yang Sy, Reiner SL: Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science. 2001, 292: 1907-1910. 10.1126/science.1059835.PubMedCrossRef Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Liv-ingston DM, Kung AL, Cereb N, Yao T-P, Yang Sy, Reiner SL: Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science. 2001, 292: 1907-1910. 10.1126/science.1059835.PubMedCrossRef
27.
go back to reference Yoshino S, Murata Y, Ohsawa M: Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J Immunol. 1998, 161: 6904-6907.PubMed Yoshino S, Murata Y, Ohsawa M: Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J Immunol. 1998, 161: 6904-6907.PubMed
28.
go back to reference Ortmann RA, Shevach EM: Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin Immunol. 2001, 98: 109-118. 10.1006/clim.2000.4961.PubMedCrossRef Ortmann RA, Shevach EM: Susceptibility to collagen-induced arthritis: cytokine-mediated regulation. Clin Immunol. 2001, 98: 109-118. 10.1006/clim.2000.4961.PubMedCrossRef
29.
go back to reference Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997, 158: 5507-5513.PubMed Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997, 158: 5507-5513.PubMed
30.
go back to reference Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol. 1997, 158: 5501-5506.PubMed Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol. 1997, 158: 5501-5506.PubMed
Metadata
Title
Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis
Authors
Charles Kaplan
Juan C Valdez
Raman Chandrasekaran
Hermann Eibel
Katalin Mikecz
Tibor T Glant
Alison Finnegan
Publication date
01-10-2001
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2001
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar383

Other articles of this Issue 1/2001

Arthritis Research & Therapy 1/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.